BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 26077464)

  • 1. The immune response in cancer: from immunology to pathology to immunotherapy.
    Giraldo NA; Becht E; Vano Y; Sautès-Fridman C; Fridman WH
    Virchows Arch; 2015 Aug; 467(2):127-35. PubMed ID: 26077464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-oncology-101: overview of major concepts and translational perspectives.
    Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy.
    Adachi K; Tamada K
    Cancer Sci; 2015 Aug; 106(8):945-50. PubMed ID: 25981182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy.
    Wang H; Franco F; Ho PC
    Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive cells in tumor immune escape and metastasis.
    Liu Y; Cao X
    J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment.
    Yang L; Li A; Lei Q; Zhang Y
    J Hematol Oncol; 2019 Nov; 12(1):125. PubMed ID: 31775797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer immune escape: implications for immunotherapy, Granada, Spain, October 3-5, 2011.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Garrido F
    Cancer Immunol Immunother; 2012 May; 61(5):739-45. PubMed ID: 22350069
    [No Abstract]   [Full Text] [Related]  

  • 8. [At the crossroads of cancer].
    Chouaib S
    Bull Cancer; 2013 Jun; 100(6):569-74. PubMed ID: 23735599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological battlefield in gastric cancer and role of immunotherapies.
    Wang M; Busuttil RA; Pattison S; Neeson PJ; Boussioutas A
    World J Gastroenterol; 2016 Jul; 22(28):6373-84. PubMed ID: 27605873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Autophagy in the Tumor Microenvironment: New Challenges and Opportunities for Regulating Tumor Immunity.
    Janji B; Berchem G; Chouaib S
    Front Immunol; 2018; 9():887. PubMed ID: 29922284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Tumor Microenvironment in Cancer Immunotherapy.
    Frankel T; Lanfranca MP; Zou W
    Adv Exp Med Biol; 2017; 1036():51-64. PubMed ID: 29275464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricks tumors use to escape from immune control.
    Whiteside TL
    Oral Oncol; 2009 Oct; 45(10):e119-23. PubMed ID: 19467917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging role of metabolic reprogramming in tumor immune evasion and immunotherapy.
    Fan C; Zhang S; Gong Z; Li X; Xiang B; Deng H; Zhou M; Li G; Li Y; Xiong W; Zeng Z; Li X
    Sci China Life Sci; 2021 Apr; 64(4):534-547. PubMed ID: 32815067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel avenues in immunotherapies for colorectal cancer.
    Pardieck IN; Jawahier PA; Swets M; van de Velde CJ; Kuppen PJ
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):465-80. PubMed ID: 26582071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy.
    Lebegge E; Arnouk SM; Bardet PMR; Kiss M; Raes G; Van Ginderachter JA
    Front Immunol; 2020; 11():1395. PubMed ID: 32733461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting adenosine in cancer immunotherapy: a review of recent progress.
    Whiteside TL
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):527-535. PubMed ID: 28399672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humanized Mice for the Study of Immuno-Oncology.
    De La Rochere P; Guil-Luna S; Decaudin D; Azar G; Sidhu SS; Piaggio E
    Trends Immunol; 2018 Sep; 39(9):748-763. PubMed ID: 30077656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer immune contexture and immunotherapy.
    Becht E; Giraldo NA; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
    Curr Opin Immunol; 2016 Apr; 39():7-13. PubMed ID: 26708937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immune evasion in breast cancer.
    Bates JP; Derakhshandeh R; Jones L; Webb TJ
    BMC Cancer; 2018 May; 18(1):556. PubMed ID: 29751789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immune response and cancer].
    El Hage F; Abouzahr-Rifai S; Meslin F; Mami-Chouaib F; Chouaib S
    Bull Cancer; 2008 Jan; 95(1):57-67. PubMed ID: 18230571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.